GDUFA IV: US FDA Wants to ‘Streamline’ Formal Meeting Structure

 
• By Derrick Gingery
  
The FDA wants to make the generic drug formal meeting system more efficient. (Shutterstock)

More from Regulation

More from Policy & Regulation